ibandronat pharmas 150 mg/1 tableta filmom obložena tableta
pharmas d.o.o. sarajevo - ibandronska kiselina - filmom obložena tableta - 150 mg/1 tableta - 1 filmom obložena tableta sadrži: 150 mg ibandronska kiselina (u obliku natrijevog ibandronat hidrata)
dasatinib pharmascience 100 mg filmom obložene tablete
pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 100 mg - urbroj: jedna filmom obložena tableta sadrži 100 mg dasatiniba (bezvodni oblik)
dasatinib pharmascience 140 mg filmom obložene tablete
pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 140 mg - urbroj: jedna filmom obložena tableta sadrži 140 mg dasatiniba (bezvodni oblik)
dasatinib pharmascience 20 mg filmom obložene tablete
pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 20 mg - urbroj: jedna filmom obložena tableta sadrži 20 mg dasatiniba (bezvodni oblik)
dasatinib pharmascience 50 mg filmom obložene tablete
pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 50 mg - urbroj: jedna filmom obložena tableta sadrži 50 mg dasatiniba (bezvodni oblik)
dasatinib pharmascience 70 mg filmom obložene tablete
pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 70 mg - urbroj: jedna filmom obložena tableta sadrži 70 mg dasatiniba (bezvodni oblik)
dasatinib pharmascience 80 mg filmom obložene tablete
pharmascience international limited, lampousas, 1, nicosia, cipar - дазатиниб - filmom obložena tableta - 80 mg - urbroj: jedna filmom obložena tableta sadrži 80 mg dasatiniba (bezvodni oblik)
risedronat pharmas 35 mg filmom obložene tablete
pharmas d.o.o., radnička cesta 47, zagreb, hrvatska - natrijev risedronat hemipentahidrat - filmom obložena tableta - 35 mg - urbroj: jedna filmom obložena tableta sadrži 35 mg natrijevog risedronata u obliku natrijevog risedronata hemipentahidrata
budesonide/formoterol teva pharma b.v.
teva pharma b.v. - budesonide, formoterol - astma - lijekovi za opstruktivne plućne bolesti dišnih putova, - budesonid / formoterol teva pharma b. je indiciran u odrasloj dobi od 18 godina i stariji. asthmabudesonide/Формотерола tewa pharma b. is indicated in the regular treatment of asthma, where use of a combination (inhaled corticosteroid and long-acting β2 adrenoceptor agonist) is appropriate: orin patients not adequately controlled with inhaled corticosteroids and “as needed” inhaled short-acting β2 adrenoceptor agonists. in patients already adequately controlled on both inhaled corticosteroids and long-acting β2 adrenoceptor agonists.
dasatinib accordpharma
accord healthcare s.l.u. - dasatinib - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antineoplastična sredstva - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.